MBX Biosciences, Inc. Common Stock Stock Analysis & AI Score
MBX Biosciences, Inc. Common Stock (MBX) has an ST Score of 53.4 (B-), driven by its Financial Strength (A) and held back by its Growth (F). Analysts rate it Buy with a $80.50 price target (+45.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
MBX Biosciences, Inc. Common Stock (MBX) has an ST Score of 53.4 (B-), driven by its Financial Strength (A) and held back by its Growth (F). Analysts rate it Buy with a $80.50 price target (+45.3% upside).
- Strongest
- Financial StrengthA
- Weakest
- GrowthF
All factor grades
- Financial StrengthA
- MomentumA-
- ProfitabilityB+
- ForecastB
- ValuationB-
- GrowthF
- Piotroski1/9
Contact
MBX stock: frequently asked questions
What is MBX's ST Score?
MBX Biosciences, Inc. Common Stock (MBX) has an ST Score of 53.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is MBX a buy, hold, or sell?
Analysts rate MBX a Buy, with a price target of $80.50 (+45.3% vs the current price). Our ST Score grades it B- (53.4/100). The ST Score is a data-driven signal, not a recommendation.
What are MBX's factor grades?
Valuation B-, Profitability B+, Financial Strength A, Momentum A-, Growth F, Forecast B.
What is MBX's valuation grade?
MBX Biosciences, Inc. Common Stock (MBX) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is MBX's growth grade?
MBX Biosciences, Inc. Common Stock (MBX) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is MBX's profitability grade?
MBX Biosciences, Inc. Common Stock (MBX) earns a profitability grade of B+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is MBX's financial strength grade?
MBX Biosciences, Inc. Common Stock (MBX) earns a financial strength grade of A, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for MBX?
The average analyst price target for MBX Biosciences, Inc. Common Stock (MBX) is $80.50 from 7 analysts, which is +45.3% versus the recent price of $55.39.
What is MBX's Piotroski score?
MBX Biosciences, Inc. Common Stock (MBX) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.